Replies to post #170689 on Elite Pharmaceuticals Inc (ELTP)

[Jimmy Joe]

Gman it has to do with exclusivity rights when approval is given whether it be a 505(b)(2) or an NDA. There is a difference here.
But even with a 505(b)(2) it may be good enough for Elite.
An NDA would be a real bombshell and would IMO supersede patents
thus bolstering patents in a way.

This may be big depending on which way Elite is going. Camargo
does only 505(b)(2)s but what if Elite took another path the FDA allowed and Camargo is still helping Elite with the process.
Money is money green is green.

Not sure of things and must talk to someone that can help me further understand the process.... a regulatory guy at my work.

Will get back to this board later.